Navigation Links
Neurocrine Biosciences Reports Third Quarter 2010 Results
Date:10/28/2010

SAN DIEGO, Oct. 28 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the quarter ended September 30, 2010.

For the third quarter of 2010, the Company reported net income of $3.3 million, or $0.06 per share, compared with a net loss of $8.2 million, or $0.21 per share, for the same period in 2009. For the nine months ended September 30, 2010, the Company reported a net loss of $10.5 million, or $0.20 per share, as compared to a net loss of $43.1 million, or $1.11 per share, for the same period last year.

The Company's balance sheet on September 30, 2010 reflected total assets of $149.9 million, including cash, investments and receivables of $140.4 million.

"The financial impact of our two recent collaboration agreements with Abbott and Boehringer Ingelheim is evident in these third quarter financial results and the cash and investments position of Neurocrine," said Timothy P. Coughlin, Chief Financial Officer of Neurocrine Biosciences. "We will continue the fiscal discipline that has been ingrained in the Company over the past three years, while advancing our lead clinical programs; elagolix, VMAT2 and Urocortin 2 and bringing new clinical candidates forward from our research and discovery platform."

Revenues for the third quarter of 2010 were $14.4 million, compared to $0.7 million for the same period in 2009. Revenues for the nine months ended September 30, 2010 were $19.8 million, compared with $2.2 million for the same period in 2009. The increase in revenue is due to our recently executed collaboration agreements with Abbott and Boehringer Ingelheim, for our GnRH (elagolix) and GPR119 programs, respectively. During the third quarter of 2010, we recognized revenue of $8.5 million from amortization of up-front license fees and $5.2 million resulting from internal and external research and d
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
2. Neurocrine Biosciences Reports First Quarter 2008 Results
3. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
4. Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
5. Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain
6. Neurocrine Biosciences Presents Elagolix Data
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results
8. Neurocrine Biosciences Reports Third Quarter 2009 Results
9. Neurocrine Advances VMAT2 Inhibitor Program
10. Neurocrine Biosciences to Present at the 21st Annual Piper Jaffray Health Care Conference
11. Neurocrine Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 02, 2015 Research and Markets ( ... "Europe Fluoroscopy Market - Growth, Trends And Forecasts (2014 ... The European market for Fluoroscopy is expected to grow ... Fluoroscopy is used to view the gastrointestinal tract, ... vessels, bile ducts or the urinary system, to open ...
(Date:6/2/2015)... June 02, 2015 Research and Markets( http://www.researchandmarkets.com/research/ctd7zx/europe ) ... - Growth, Trends And Forecasts (2014 - 2019)" report ... dominated by the Germany . This is ... nations such as Poland are the ... equipment can be segmented on the basis of Product (Film ...
(Date:6/2/2015)... , June 02, 2015 Research ... addition of Jain PharmaBiotech,s new report "Drug ... Markets and Companies" to their offering. ... system (CNS) is a challenge in the treatment ... into the CNS or administered systematically (e.g., by ...
Breaking Medicine Technology:European Fluoroscopy Market Report 2014-2019 - Growth, Trends And Forecasts 2Europe Mammography Market Report 2014-2019 - Growth, Trends And Forecasts 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 3
... Reportlinker.com announces that a new market research report ... 3D Medical Imaging Industry http://www.reportlinker.com/p098258/Global-3D-Medical-Imaging-Industry.html ... markets for 3D Medical Imaging in US$ Million by ... report provides separate comprehensive analytics for the US, Canada, ...
... YORK, Feb. 23, 2011 Reportlinker.com announces that ... its catalogue: Global Artificial Organs ... This report analyzes the worldwide markets ... following Product Segments: Artificial Heart, Artificial Kidneys, Artificial ...
Cached Medicine Technology:Reportlinker Adds Global Artificial Organs Industry 2
(Date:6/2/2015)... Bitscape Infotech today announced it has ... Small and Midsized Cloud Solutions Award. The company was ... for demonstrating excellence in innovation and implementation of customer ... as no surprise to us as we feel our ... worldwide level by Microsoft. We will continue to lead ...
(Date:6/2/2015)... of Prussia, PA (PRWEB) June 02, 2015 ... Process Outsourcing solutions for health plans in the Medicare ... their participation as a sponsor and exhibitor at AHIP’s ... group, America’s Health Insurance Plans. The conference will be ... Health exhibition booth, #1303, will offer opportunities for attendees ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 “ Radaris ” ... which takes a look at the latest and coolest applications ... the host of AppWatch and technology expert, conducted the app ... the data they need on a person. , According to ... publication even goes on to explain that curiosity is a ...
(Date:6/2/2015)... Washington, DC (PRWEB) June 02, 2015 Did ... you’re wondering what to get him, his family isn’t asking ... Renegades , the team walking in Saturday’s Cure HHT DC ... a genetic disease that causes malformed blood vessels leading to ... began to appear when Ryder was 3 years old ...
(Date:6/2/2015)... 02, 2015 Tronics, a designer and ... growth strategy to benefit from the significant growth expected ... May 2015 Status of the MEMS Industry report, we ... reach $6.6B in 2020,” says Frederic Breussin, Business Unit ... , The analyst adds that “although the BioMEMS market ...
Breaking Medicine News(10 mins):Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 3Health News:TMG Health to Sponsor and Exhibit at AHIP’s Institute 2015 2Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2Health News:Six-Year-Old Walks to Bring Awareness to Genetic Disease 2Health News:Tronics Aims to Benefit from Major Growth of Sensors and Related Technologies for Healthcare Applications 2
... Neuroimagingis it voodoo, new phrenology, or scientific breakthrough? ... this special section on fMRI in Perspectives ... New Phrenology, or Scientific Breakthrough? Introduction to Special ... Ed Diener In response to the widespread ...
... -- If you have trouble understanding people with regional ... understand what they,re saying, a new study suggests. ... sentences spoken in an unfamiliar accent. But before they ... on how to respond to the sentences. Some were ...
... Reporter , WEDNESDAY, Dec. 8 (HealthDay News) -- Sudden infant death ... mysterious and terrifying killer of newborns. But medical researchers now ... die of SIDS, an advance that could save hundreds of ... of SIDS tend to have significantly lower amounts of serotonin than ...
... Dec. 8 (HealthDay News) -- A new U.S. study ... severely in black children than white children. The ... said the researchers at the University of Alabama at ... black and 22 white children with MS, a chronic ...
... Patients who have complications after colorectal cancer surgery ... is clearly recommended for their diagnosis, a new study ... In addition, patients with complications were more than ... more than 120 days after diagnosis or two months ...
... an irresistible force, has proven 99 percent effective in ... causing $2 billion in annual loses to the cattle ... ACS, biweekly Journal of Agricultural and Food Chemistry ... flies not only inflict painful bites, but also transmit ...
Cached Medicine News:Health News:fMRI special section of Perspectives on Psychological Science 2Health News:fMRI special section of Perspectives on Psychological Science 3Health News:Serotonin May Be the Key to SIDS 2Health News:Serotonin May Be the Key to SIDS 3Health News:Surgery complications linked to chemotherapy delay, U-M study finds 2
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With reinforced ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTC/1Q chairs are recommended for ... clean room, static control, health care ...
Medicine Products: